254 related articles for article (PubMed ID: 18753873)
1. Persistent differences in the antiviral effects of highly active antiretroviral therapy in the blood and male genital tract.
Pasquier CJ; Moinard N; Sauné K; Souyris C; Lavit M; Daudin M; Izopet J; Bujan L
AIDS; 2008 Sep; 22(14):1894-6. PubMed ID: 18753873
[No Abstract] [Full Text] [Related]
2. Persistent HIV RNA shedding in semen despite effective antiretroviral therapy.
Sheth PM; Kovacs C; Kemal KS; Jones RB; Raboud JM; Pilon R; la Porte C; Ostrowski M; Loutfy M; Burger H; Weiser B; Kaul R;
AIDS; 2009 Sep; 23(15):2050-4. PubMed ID: 19710596
[TBL] [Abstract][Full Text] [Related]
3. Detection of HIV-1 RNA in seminal plasma samples from treated patients with undetectable HIV-1 RNA in blood plasma.
Marcelin AG; Tubiana R; Lambert-Niclot S; Lefebvre G; Dominguez S; Bonmarchand M; Vauthier-Brouzes D; Marguet F; Mousset-Simeon N; Peytavin G; Poirot C
AIDS; 2008 Aug; 22(13):1677-9. PubMed ID: 18670231
[TBL] [Abstract][Full Text] [Related]
4. Impact of antiretroviral therapy duration and intensification on isolated shedding of HIV-1 RNA in semen.
Osborne BJ; Sheth PM; Yi TJ; Kovacs C; Benko E; Porte Cl; Huibner S; Le AQ; Danroth R; Baraki B; Mazzulli T; Brumme ZL; Kaul R
J Infect Dis; 2013 Apr; 207(8):1226-34. PubMed ID: 23329849
[TBL] [Abstract][Full Text] [Related]
5. [The male genital tract: A host for HIV].
Le Tortorec A; Dejucq-Rainsford N
Gynecol Obstet Fertil; 2007 Dec; 35(12):1245-50. PubMed ID: 18035579
[TBL] [Abstract][Full Text] [Related]
6. Impact of adding raltegravir to antiretroviral regimens in patients with blood viral suppression but persistent seminal viral shedding.
Fiore JR; Zoboli F; Di Stefano M; Faleo G; Fasano M; Santantonio TA
AIDS; 2016 Apr; 30(7):1144-6. PubMed ID: 27028146
[No Abstract] [Full Text] [Related]
7. Frequent reactivation of herpes simplex virus among HIV-1-infected patients treated with highly active antiretroviral therapy.
Posavad CM; Wald A; Kuntz S; Huang ML; Selke S; Krantz E; Corey L
J Infect Dis; 2004 Aug; 190(4):693-6. PubMed ID: 15272395
[TBL] [Abstract][Full Text] [Related]
8. Factors associated with changes in HIV shedding in semen.
Fiscus SA; Vernazza PL; Gilliam B; Dyer J; Eron JJ; Cohen MS
AIDS Res Hum Retroviruses; 1998 Apr; 14 Suppl 1():S27-31. PubMed ID: 9581881
[TBL] [Abstract][Full Text] [Related]
9. Treatment of infants coinfected with HIV-1 and cytomegalovirus with combination antiretrovirals and ganciclovir.
Saitoh A; Viani RM; Schrier RD; Spector SA
J Allergy Clin Immunol; 2004 Oct; 114(4):983-5. PubMed ID: 15480350
[No Abstract] [Full Text] [Related]
10. [Antiretroviral therapy of HIV infection. German-Austrian guidelines (position in September 2008)].
;
Dtsch Med Wochenschr; 2009 Jan; 134 Suppl 1():S4-15. PubMed ID: 19172554
[No Abstract] [Full Text] [Related]
11. Outbreaks of genital herpes: effects on plasma HIV type 1 viral loads in individuals receiving highly active antiretroviral therapy.
Lee V; Foley E; Barton SE; Patel R
J Infect Dis; 2004 Dec; 190(11):2057-8. PubMed ID: 15529276
[No Abstract] [Full Text] [Related]
12. Disproportionately high semen shedding of HIV is associated with compartmentalized cytomegalovirus reactivation.
Sheth PM; Danesh A; Sheung A; Rebbapragada A; Shahabi K; Kovacs C; Halpenny R; Tilley D; Mazzulli T; MacDonald K; Kelvin D; Kaul R
J Infect Dis; 2006 Jan; 193(1):45-8. PubMed ID: 16323130
[TBL] [Abstract][Full Text] [Related]
13. Risk of high-level viraemia in HIV-infected patients on successful antiretroviral treatment for more than 6 months.
Engsig FN; Omland LH; Larsen MV; Rasmussen LD; Qvist T; Gerstoft J; Obel N
HIV Med; 2010 Aug; 11(7):457-61. PubMed ID: 20158527
[TBL] [Abstract][Full Text] [Related]
14. Raltegravir-based highly active antiretroviral therapy has beneficial effects on the renal function of human immunodeficiency virus-infected patients after solid organ transplantation.
Moreno A; Pérez-Elías MJ; Casado JL; Fortún J; Bárcena R; Quereda C; Del Campo S; Gutiérrez C; Pastor O; Nuño J; Fernandez A; Moreno S
Liver Transpl; 2010 Apr; 16(4):530-2. PubMed ID: 20213666
[No Abstract] [Full Text] [Related]
15. Antiviral effect of maraviroc in semen: a case report.
Pasquier C; Moinard N; Sauné K; Daudin M; Trancart S; Massip P; Izopet J; Bujan L
Antivir Ther; 2012; 17(5):933-6. PubMed ID: 22297568
[TBL] [Abstract][Full Text] [Related]
16. Duration of an intermittent episode of viremia.
Di Mascio M; Percus JK; Percus OE; Markowitz M; Ho DD; Perelson AS
Bull Math Biol; 2005 Jul; 67(4):885-900. PubMed ID: 15893558
[TBL] [Abstract][Full Text] [Related]
17. British HIV Association Guidelines for the treatment of HIV-1-infected adults with antiretroviral therapy 2008.
Gazzard BG; Anderson J; Babiker A; Boffito M; Brook G; Brough G; Churchill D; Cromarty B; Das S; Fisher M; Freedman A; Geretti AM; Johnson M; Khoo S; Leen C; Nair D; Peters B; Phillips A; Pillay D; Pozniak A; Walsh J; Wilkins E; Williams I; Williams M; Youle M;
HIV Med; 2008 Oct; 9(8):563-608. PubMed ID: 18826546
[No Abstract] [Full Text] [Related]
18. Combination antiretroviral therapy failure and HIV super-infection.
Bezemer D; van Sighem A; de Wolf F; Cornelissen M; van der Kuyl AC; Jurriaans S; van der Hoek L; Prins M; Coutinho RA; Lukashov VV
AIDS; 2008 Jan; 22(2):309-11. PubMed ID: 18097235
[TBL] [Abstract][Full Text] [Related]
19. Viral load in semen.
Colvin R
Common Factor; 1997 Nov; (No 11):8-9. PubMed ID: 11364849
[TBL] [Abstract][Full Text] [Related]
20. Continued correspondence 'Will ART rollout in Africa drive an epidemic of drug-resistant HIV?'.
Hastings IM; Lalloo DG; Khoo SH
AIDS; 2007 Jan; 21(2):258-9; author reply 259-60. PubMed ID: 17197825
[No Abstract] [Full Text] [Related]
[Next] [New Search]
